Another important protein, LMP2A, promotes tumor cell immune escape through the PI3K/Akt/mTOR pathway, while inhibiting the expression of MHC class I molecules and reducing tumor cell immunogenicity [141,142]. The gene discussed is AKT1; the disease is neoplasm.